Over the last few years, great emphasis has been given to develop ruthenium complexes to
act as target specified chemotherapeutic agents. Indeed, there are few reviews available …

The small molecule anticancer agent cisplatin and its Pt (II) analogs carboplatin and
oxaliplatin are widely used to treat a variety of tumorigenic diseases. Despite their structural …

Mitochondria play critical roles in the regulation of the proliferation and apoptosis of
cancerous cells. Nanosystems for targeted delivery of cargos to mitochondria for cancer …

Several anticancer drugs such as cisplatin, and its analogues, epirubicin, and doxorubicin
are well known for their anticancer activity but the therapeutic value of these drugs comes …

The reaction of the Ru (PPh3) 3Cl2 with HL1− 3− OH (− OH stands for the oxime hydroxyl
group; HL1− OH= diacetylmonoxime‐S‐benzyldithiocarbazonate; HL2− OH …

Four new oxidovanadium [VVOL1–4 (ema)] complexes (1–4) have been synthesized using
tridentate binegative ONO donor ligands H2L1–4 [H2L1:(E)-N′-(2-hydroxybenzylidene) …

Photodynamic therapy (PDT) is a minimally invasive clinical protocol that combines a
nontoxic photosensitizer (PS), appropriate visible light, and molecular oxygen for cancer …

Supramolecular coordination complexes formed by coordination-induced assembly not only
avoid the loss of activity of precursors but also provide an efficient way for controlled release …

Many terpyridines and their metal complexes are known to exhibit remarkable potential for
the interaction of biological targets. Notably, a subtle change in the structure of the ligand …

Due to a number of unpleasant considerations, marketed drugs have steadily lost their
importance in the treatment of cancer. In order to find a viable cancer cell diagnostic agent …